Assignee
NEURODON CORP
US·5 granted patents·1 pending application·3 citations·filing 2021–2024
Top patents by PatentIndex Score
6 records- 0193US11890279B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted Feb 6, 2024·1 cites·4 claims
- 0289US11730729B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Aug 22, 2023·1 cites·4 claims
- 0387US12144806B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2024·Granted Nov 19, 2024·0 cites·5 claims
- 0487US11827626B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Nov 28, 2023·1 cites·8 claims
- 0586US2025248990A1Quinolines that modulate serca and their use for treating diseaseNEURODON CORP·Filed 2024·Application pending·0 cites
- 0685US11992487B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted May 28, 2024·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when NEURODON CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →